Percentage of patients with hypokalemia (potassium <3.5 mEq/L), hyperkalemia (potassium >5.5 mEq/L) and hyperphosphatemia (phosphate >5.5 mg/dL) before (black/gray columns) and aft... by Daniela Peruzzo (11570702)

Stx2 and SubAB decrease HGEC viability. by María M. Amaral (439445)

Full-length PRR expression increases and sPRR secretion decreases in the absence of PACE4 in mouse. by Amro H. Mohammad (15081540)

Excitotoxicity-induced decrease in GAD65/67 activity. by Márcio S. Baptista (365618)

Blocking C5L2 decreased C5a-primed neutrophils expression of membrane-bound PR3 (mPR3). by Jian Hao (160736)

Relative decreases in VP mean weights using -DDE against TP controls in nine laboratories (Lab) by William Owens (20777)

IL-1β decreases RBP4 production. by Primoz Kotnik (382835)

TGF-β1 decreases RECK expression in fibroblasts. by Jaime Gutiérrez (401710)

Relative decreases in VP mean weights using VIN against TP controls in eight laboratories (Lab) by William Owens (20777)

FLZ decreased the expression of phospho-APP and APP-CTF. by Xiu-Qi Bao (479278)

Receptor specific silencing decreases NGF induced apoptosis. by Alessandra Micera (294762)

“…A 37.5%-decrease (*) and a 50%-decrease (**) of apoptotic signal were detected respectively in p75^NTR-siRNA and p75^NTR/trkA^NGFR-siRNA (p<.05).…”

<i>ism1</i> knockdown decreases erythrocytes. by Arturo Berrun (5216003)

Effects of H5 (20 and 40 mg/kg, p.o.), and diazepam (2.5 mg/kg, i.p.) in the Rota-rod test in mice. by Maria Alice Miranda Bezerra Medeiros (11752002)

Chemotherapy decreases cell proliferation in the adult mouse CNS by Joerg Dietrich (35101)

Cytokine dependent decrease in vSMC viability after type I NKT cell activation. by Gijs H. M. van Puijvelde (500345)

Inhibition of Hh signaling decreases hMSC proliferation. by Magali Plaisant (230886)

Loss of Sidt2 decreased insulin granule exocytosis. by Jialin Gao (420257)

S5 File - by Wenxin Ye (14392899)

OCA alone markedly decreases and combined with Gemcitabine or Cisplatin abrogates growth of iCCA xenografts. by S. Di Matteo (6260417)

“…After 4 weeks, when the tumor size was approximately 100 mm³ (T₀) mice were treated with OCA (0.03% w/w, 30 mg/kg) alone or combined with Cisplatin (2.4 mg/Kg in 100 μl) or Gemcitabine (1.05 mg/Kg in 100 μl) for 5 additional weeks. a) Results are expressed as percent increase in tumor volume at different time points. …”

Positive modulation of mGluR5 decreases spine density in the nucleus accumbens but not in the dorsal striatum. by Kellie S. Gross (3115299)

“…<p>(A) Twenty-four hours after systemic administration, CDPPB (5–10 mg/kg, <i>n</i> = 18 animals) decreased dendritic spine density and frequency of small head diameter spines (0.2 μm bin) compared to vehicle control (<i>n</i> = 8) in the nucleus accumbens core. …”